Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: telephonics who wrote (1675)	9/21/2001 12:18:37 PM
From: Oak Tree	Respond to of 2515

<<The response by the Oncologists,Hemotologists and the cancer research community in general have been overwhelmingly positive to the data released via professional society conventions.>> I completely agree. The response so far has been very positive. The reasons for that a many-fold. Partly the benefit that has been seen for some patients. The enthusiasm for endostatin far exceeded the enthusiasm for C225. The enthusiasm for inteferon likewise as well as tumor necrosis factor and others. All these drugs had there brief period in the sun. And when they were the sky was bright and clear. The clouds eventually came in a big way. Will it take a month, a year, two years? It won't take 3 years.